Impact of polyvascular disease on baseline characteristics, management and mortality in acute myocardial infarction. The Alliance project

Archives of Cardiovascular Diseases
Anouk MeizelsALLIANCE investigators on behalf of the working group on Epidemiology of the French Society of Cardiology

Abstract

A substantial number of patients with acute myocardial infarction (AMI) have polyvascular disease (PolyVD), defined as cerebrovascular disease (CVD), peripheral arterial disease (PAD) or both. To investigate the impact of PolyVD on baseline characteristics, management and outcomes. The Alliance project is a multicentre, cross-sectional database of patients with myocardial infarction throughout France from 2000 to 2005. A pooled analysis of individual patient data was performed by aggregating data from five registries, representing 9783 patients hospitalized for acute coronary syndromes. Data were collected on history of PAD and CVD and correlated to baseline characteristics, management and hospital outcomes. Eight thousand nine hundred and four patients had full datasets for this analysis (13% with a history of CVD or PAD, 87% without). Patients with PolyVD were older (72 vs 65 years, p<0.0001), had a more frequent history of AMI (26% vs 15%, p<0.0001), percutaneous coronary intervention (PCI), coronary artery bypass graft (CABG), renal insufficiency (12% vs 3%, p<0.0001) and consistently more risk factors for atherosclerosis (hypertension, dyslipidaemia, smoking, diabetes), but less frequently a body mass index>30 kg/m(2) (14....Continue Reading

References

Dec 31, 2002·European Heart Journal·Michel E BertrandUNKNOWN Task Force on the Management of Acute Coronary Syndromes of the European Society of Cardiology
Nov 11, 2005·Clinical Trials : Journal of the Society for Clinical Trials·Mark C SimmondsSimon G Thompson
Jan 13, 2006·JAMA : the Journal of the American Medical Association·Deepak L BhattUNKNOWN REACH Registry Investigators
Mar 22, 2007·JAMA : the Journal of the American Medical Association·Ph Gabriel StegUNKNOWN REACH Registry Investigators
May 3, 2007·JAMA : the Journal of the American Medical Association·Keith A A FoxUNKNOWN GRACE Investigators

❮ Previous
Next ❯

Citations

Jan 1, 2013·Global Cardiology Science & Practice·Ayman El-MenyarHassan Al-Thani
May 28, 2014·Revista Española De Cardiología·Luciano Consuegra-SánchezMarta Vicente-Gilabert
Jan 25, 2012·TheScientificWorldJournal·Hassan Al ThaniJassim Al Suwaidi
Sep 16, 2015·Archives of Cardiovascular Diseases·Gregory Ducrocq, Philippe Gabriel Steg
Jan 6, 2012·International Journal of Vascular Medicine·Hassan A Al-ThaniJassim Al Suwaidi
Mar 19, 2013·Journal of the American College of Cardiology·Rajesh V SwaminathanDmitriy N Feldman
Apr 23, 2013·International Journal of Cardiology·Michael MoharebUNKNOWN Canadian GRACE/GRACE2/CANRACE Investigators
Jul 26, 2011·International Journal of Cardiology·Thomas G BriffaMichael Hobbs
Nov 20, 2014·Journal of Cardiopulmonary Rehabilitation and Prevention·Tomasz P KowalSherry L Grace
Jun 2, 2012·Clinical Cardiology·Carlos Cantú-BritoUNKNOWN REACH Latin America Collaborative Group
Sep 8, 2020·International Angiology : a Journal of the International Union of Angiology·Pavel PoredosPier L Antignani
Sep 21, 2020·Annales de cardiologie et d'angéiologie·J T NiamkeyR N'Guetta
Apr 15, 2021·Kardiologiia·V G GrachevO G Smolenskaya
May 20, 2021·Circulation Reports·Mitsuhiro TakeuchiTohru Minamino

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.